-
Mashup Score: 0Low-carbohydrate, high-fat diet reduced fatty liver, improved type 2 diabetes control - 2 year(s) ago
LONDON — A low-carbohydrate, high-fat diet significantly improved nonalcoholic fatty liver disease activity score and HbA1c more than a high-carbohydrate, low-fat diet in people with type 2 diabetes mellitus, according to a researcher here.
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet
-
Mashup Score: 6
Tirzepatide showed a significant reduction in LFC and VAT and ASAT volumes compared with insulin degludec in this subpopulation of patients with type 2 diabetes in the SURPASS-3 study. These data provide additional evidence on the metabolic effects of this novel dual GIP and GLP-1 receptor agonist.
Categories: Endocrinology, Latest HeadlinesTweet-
In the June Issue: Effect of #tirzepatide versus insulin degludec on #liver #fat content & #abdominal #adipose tissue in people with type 2 #diabetes (SURPASS-3 MRI): a substudy of the phase 3 SURPASS-3 trial https://t.co/O9h1v8Z1VA #T2D #NAFLD
-
-
Mashup Score: 3
Tirzepatide showed a significant reduction in LFC and VAT and ASAT volumes compared with insulin degludec in this subpopulation of patients with type 2 diabetes in the SURPASS-3 study. These data provide additional evidence on the metabolic effects of this novel dual GIP and GLP-1 receptor agonist.
Categories: Endocrinology, Latest HeadlinesTweet-
Online—Effect of #tirzepatide versus insulin degludec on #liver #fat content and abdominal #adipose tissue in people with type 2 #diabetes (#SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial https://t.co/O9h1v8Hqx0 #T2D #NAFLD
-
-
Mashup Score: 4
Tirzepatide showed a significant reduction in LFC and VAT and ASAT volumes compared with insulin degludec in this subpopulation of patients with type 2 diabetes in the SURPASS-3 study. These data provide additional evidence on the metabolic effects of this novel dual GIP and GLP-1 receptor agonist.
Categories: Endocrinology, Latest HeadlinesTweet-
Online—Effect of #tirzepatide versus insulin degludec on #liver #fat content and #abdominal #adipose tissue in people with type 2 #diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial https://t.co/O9h1v8Z1VA #T2D #NAFLD
-
-
Mashup Score: 3
Tirzepatide showed a significant reduction in LFC and VAT and ASAT volumes compared with insulin degludec in this subpopulation of patients with type 2 diabetes in the SURPASS-3 study. These data provide additional evidence on the metabolic effects of this novel dual GIP and GLP-1 receptor agonist.
Categories: Endocrinology, Latest HeadlinesTweet-
Online—Effect of #tirzepatide versus #insulin #degludec on #liver #fat content and abdominal adipose tissue in people with type 2 #diabetes (#SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial https://t.co/O9h1v8Z1VA #T2D #NAFLD
-
-
Mashup Score: 0
Tirzepatide showed a significant reduction in LFC and VAT and ASAT volumes compared with insulin degludec in this subpopulation of patients with type 2 diabetes in the SURPASS-3 study. These data provide additional evidence on the metabolic effects of this novel dual GIP and GLP-1 receptor agonist.
Categories: Endocrinology, Latest HeadlinesTweet-
Online—Effect of #tirzepatide versus #insulin #degludec on #liver #fat content & abdominal adipose tissue in people with type 2 #diabetes (#SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 SURPASS-3 trial https://t.co/O9h1v8Z1VA #T2D #NAFLD
-
-
Mashup Score: 2
Tirzepatide showed a significant reduction in LFC and VAT and ASAT volumes compared with insulin degludec in this subpopulation of patients with type 2 diabetes in the SURPASS-3 study. These data provide additional evidence on the metabolic effects of this novel dual GIP and GLP-1 receptor agonist.
Categories: Endocrinology, Latest HeadlinesTweet-
New—Effect of #tirzepatide versus #insulin #degludec on #liver #fat content & abdominal #adipose tissue in people with type 2 #diabetes (SURPASS-3 MRI): a substudy of the randomised, open-label, parallel-group, phase 3 #SURPASS-3 trial https://t.co/O9h1v8Z1VA #T2D #MRI #NAFLD
-
-
Mashup Score: 76
An increase in fat mass is considered to be an important risk factor for the worldwide increase in type 2 diabetes and cardiovascular disease. However, for a given fat mass, there is a large variability in the risk prediction of these cardiometabolic diseases. For example, some lean people unexpectedly have a risk of type 2 diabetes and cardiovascular disease that is similar to the increased risk…
Categories: Healthcare Professionals, Latest HeadlinesTweet-
RT @TheLancetEndo: Causes, consequences, and treatment of metabolically unhealthy #fat distribution https://t.co/DEJvH8QKO6 #obesity #adip…
-
-
Mashup Score: 25
An increase in fat mass is considered to be an important risk factor for the worldwide increase in type 2 diabetes and cardiovascular disease. However, for a given fat mass, there is a large variability in the risk prediction of these cardiometabolic diseases. For example, some lean people unexpectedly have a risk of type 2 diabetes and cardiovascular disease that is similar to the increased risk…
Categories: Hem/Oncs, Latest HeadlinesTweet-
RT @TheLancetEndo: Causes, consequences, and treatment of metabolically unhealthy #fat distribution https://t.co/DEJvH8QKO6 #obesity #adip…
-
-
Mashup Score: 4
An increase in fat mass is considered to be an important risk factor for the worldwide increase in type 2 diabetes and cardiovascular disease. However, for a given fat mass, there is a large variability in the risk prediction of these cardiometabolic diseases. For example, some lean people unexpectedly have a risk of type 2 diabetes and cardiovascular disease that is similar to the increased risk…
Categories: Endocrinology, Latest HeadlinesTweet-
Causes, consequences, and treatment of metabolically unhealthy #fat distribution https://t.co/DEJvH8QKO6 #obesity #adiposity https://t.co/PaoHMk5iys
-
A low #carbohydrate, high #fat #diet significantly improved #NALFD activity score and HbA1c more than a high-carbohydrate, low-fat diet in people with #type2diabetes @EASLnews @Camilla_Dalby #ILC2022 #MedTwitter #hepatology https://t.co/SjfvexN7bi